Nexia Biotechnologies Inc Company Profile

04:28 EDT 30th May 2015 | BioPortfolio

Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and BioSteelR.On March 7, 2005, Nexia's, shareholders approved the sale of substantially all its operations and assets related to ProtexiaR to PharmAthene (www.pharmathene.com), a privately held biotechnology company focused on the development of biodefense therapeutics, based in Annapolis, Maryland, USA.

Location

P.O. BOX 187Branch Jean-Talon
Montreal
Quebec
H1S 2Z2
Canada

Contact

Phone: 514.586.3942
Fax: 514.371.7880
Email: investors@nexiabiotech.com


News Articles [124 Associated News Articles listed on BioPortfolio]

Nexia, Inst. of Plant Genetics in transgenics deal

Nexia Biotechnologies (complex recombinant proteins) will collaborate with the Institute of Plant Genetics & Crop Plant Research (IPG) in developing a method for manufacturing spider silk proteins in ...

ExpreS2ion Biotechnologies – production in Drosophila S2 cells

ExpreS2ion Biotechnologies is a world leading contract research organization (CRO) for the production in Drosophila Schneider-2 (S2) cells using its proprietary and complete S2 recombinant protein tec...

Adaptive Biotechnologies to purchase immunosequencing firm

Adaptive Biotechnologies said it secured $94 million in private equity funding and used the money to acquire Sequenta, an imm -More- 

Minerva Biotechnologies Corp.

Minerva Biotechnologies Corp. is engaged in the development of novel biosensors.

Adaptive Biotechnologies Series F financing

Adaptive Biotechnologies announced the completion of Adaptive’s Series F financing round with a $195 million investment to support several strategic growth initiatives. This round was led by Matrix ...

Lion Biotechnologies seeks FDA's approval for trial of melanoma candidate

Lion Biotechnologies has submitted an application to the FDA for approval to initiate a midstage trial of its autologous T ce -More- 

Matinas BioPharma acquires Aquarius BioTechnologies

Matinas BioPharma Holdings has acquired all of the outstanding stock of Aquarius BioTechnologies, an innovative bio-delivery drug discovery company with a novel and proprietary lipid-crystal nano-part...

Adaptive Biotechnologies acquires fellow immunosequencing firm Sequenta

Using proceeds from its concurrent $94mm Series E round, Adaptive Biotechnologies Corp. acquired fellow private clinical diagnostics developer Sequenta Inc. (immunosequencing).

Drugs and Medications [0 Results]

None

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Camelid Genetics and Reproductive Biotechnologies.

Federalism and bioethics.

Abstract The absence of comprehensive federal oversight of human biotechnologies in the United States continues to stimulate academic discourse on the relative merits of European-style regulatory agen...

Don't Mind the Gap: Intuitions, Emotions, and Reasons in the Enhancement Debate.

Reliance on intuitive and emotive responses is widespread across many areas of bioethics, and the current debate on biotechnological human enhancement is particularly interesting in this respect. A st...

All-in-one assay for β-D-galactoside sialyltransferases: quantification of productive turnover, error hydrolysis and site selectivity.

Sialyltransferases are important enzymes of glycobiology and the related biotechnologies. The development of sialyltransferases calls for access to quick, inexpensive and robust analytical tools. We e...

Cyborgs, biotechnologies, and informatics in health care - new paradigms in nursing sciences.

Nursing Sciences are at a moment of paradigmatic transition. The aim of this paper is to reflect on the new epistemological paradigms of nursing science from a critical approach. In this paper, we ide...

Clinical Trials [0 Results]

None

Companies [101 Associated Companies listed on BioPortfolio]

Nexia Biotechnologies Incorporated

Nexia Biotechnologies is one of the world's largest producers of authentic recombinant spider silk, and a leading North American animal transgenic company. Nexia manufactures biomaterials and therapeu...

Nexia Biotechnologies Inc

Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and ...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Nexia Holdings, Inc.

Genemed Biotechnologies Incorporated

Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides

More Information about "Nexia Biotechnologies Inc" on BioPortfolio

We have published hundreds of Nexia Biotechnologies Inc news stories on BioPortfolio along with dozens of Nexia Biotechnologies Inc Clinical Trials and PubMed Articles about Nexia Biotechnologies Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nexia Biotechnologies Inc Companies in our database. You can also find out about relevant Nexia Biotechnologies Inc Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Biotechnology - Biotech
Latest News Clinical Trials Research Drugs Reports Corporate
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record